Form 4 for IDXX Idexx Laboratories
Accepted 2023-08-31 00:00:00 ET · period of report 2023-08-29 · accession 0000874716-23-000113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-31 | 2023-08-29 | IDXX | POLEWACZYK JAMES F | EVP | S - Sale+OE | $510.56 | -22.9K | 32.4K | -41% | -$11.70M |
| DM | 2023-08-31 | 2023-08-29 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | $144.21 | +16.9K | 19.4K | +687% | +$2.44M |
| DM | 2023-08-31 | 2023-08-29 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | -16.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-29 | S | D | 2,887 | $511.22 | 10,037.99 | D | — | — | (F7) Represents the weighted average price of the shares sold ranging from a low of $510.96 to a high of $511.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2023-08-29 | S | D | 7,473 | $511.03 | 12,924.99 | D | — | — | (F6) Represents the weighted average price of the shares sold ranging from a low of $510.73 to a high of $511.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Common | Common Stock | 2023-08-29 | S | D | 3,318 | $510.47 | 20,397.99 | D | — | — | (F5) Represents the weighted average price of the shares sold ranging from a low of $509.93 to a high of $510.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Common | Common Stock | 2023-08-29 | S | D | 6,186 | $510.38 | 23,715.99 | D | — | — | (F4) Represents the weighted average price of the shares sold ranging from a low of $509.69 to a high of $510.68 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 5 | Common | Common Stock | 2023-08-29 | S | D | 2,545 | $509.32 | 29,901.99 | D | — | — | (F3) Represents the weighted average price of the shares sold ranging from a low of $508.63 to a high of $509.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 6 | Common | Common Stock | 2023-08-29 | S | D | 500 | $508.96 | 32,446.99 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $508.76 to a high of $509.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 7 | Common | Common Stock | 2023-08-29 | M | A | 5,865 | $178.26 | 32,946.99 | D | — | — | |
| 8 | Common | Common Stock | 2023-08-29 | M | A | 560 | $178.26 | 27,081.99 | D | — | — | |
| 9 | Common | Common Stock | 2023-08-29 | M | A | 7,151 | $141.60 | 26,521.99 | D | — | — | |
| 10 | Common | Common Stock | 2023-08-29 | M | A | 2,627 | $68.75 | 18,664.99 | D | — | — | (F1) Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023. |
| 11 | Common | Common Stock | 2023-08-29 | M | A | 706 | $141.60 | 19,370.99 | D | — | — | |
| 12 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2023-08-29 | M | D | 7,151 | $0.00 | 0 | D | $141.60 · — to 2027-02-13 | 7,151 Common Stock | (F10) Grant of option to buy 7,151 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018. |
| 13 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2023-08-29 | M | D | 5,865 | $0.00 | 0 | D | $178.26 · — to 2028-02-13 | 5,865 Common Stock | (F12) Grant of option to buy 5,865 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019. |
| 14 | Derivative | Incentive Stock Option (right-to-buy) | 2023-08-29 | M | D | 706 | $0.00 | 0 | D | $141.60 · — to 2027-02-13 | 706 Common Stock | (F9) Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022. |
| 15 | Derivative | Incentive Stock Option (right-to-buy) | 2023-08-29 | M | D | 560 | $0.00 | 0 | D | $178.26 · — to 2028-02-13 | 560 Common Stock | (F11) Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023. |
| 16 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2023-08-29 | M | D | 2,627 | $0.00 | 0 | D | $68.75 · — to 2026-02-13 | 2,627 Common Stock | (F8) Grant of option to buy 12,627 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017. |